16th April 2019 Content supplied by: GenePOC Inc.
CE Mark for GenePOC Carba Assay for Use With Revogene™ Device
GenePOC Inc., has announced its third test to be CE marked - the GenePOC Carba assay, for use with the revogene™ device.
The GenePOC Carba assay is a qualitative, in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with carbapenem-non-susceptibility. The assay can provide results from one up to eight samples in approximately 70 minutes using characterized carbapenem-non-susceptible isolated colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa.
The revogene is an automated and stand-alone device, enabling testing of single-use proprietary microfluidic cartridges with fluorescence-based real-time polymerase chain reaction technology to deliver an accurate diagnosis.
Date Published: 16th April 2019
Source article link: View